Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Tecovirimat, sold under the brand name Tpoxx among others, is an antiviral medication with activity against orthopoxviruses such as smallpox and mpox. In 2018 it was the first antipoxviral drug approved in the United States.
History, Community, Culture & Applications
Explore the main themes, entities and connections around Tecovirimat. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
drug mpox smallpox treatment virus clinical approved national first trials orthopoxviruses tpoxx us 2022 united states disease fda 2018 vaccinia
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Tecovirimat | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Tecovirimat | AHFS/Drugs.com | Monograph | 1.00 | infobox |
| Tecovirimat | ATC code | J05AX24 (WHO) | 1.00 | infobox |
| Tecovirimat | CAS Number | 869572-92-9 | 1.00 | infobox |
| Tecovirimat | ChEMBL | ChEMBL1257073 Y | 1.00 | infobox |
| Tecovirimat | ChemSpider | 17281586 Y | 1.00 | infobox |
| Tecovirimat | DrugBank | DB12020 | 1.00 | infobox |
| Tecovirimat | Formula | C19H15F3N2O3 | 1.00 | infobox |
| Tecovirimat | KEGG | D09390 Y | 1.00 | infobox |
| Tecovirimat | KEGG | as monohydrate: D11557 Y | 1.00 | infobox |
| Tecovirimat | Legal status | CA: ℞-only | 1.00 | infobox |
| Tecovirimat | Legal status | US: ℞-only | 1.00 | infobox |
| Tecovirimat | Legal status | EU: Rx-only | 1.00 | infobox |
| Tecovirimat | License data | US DailyMed: Tecovirimat | 1.00 | infobox |
| Tecovirimat | Molar mass | 376.335 g·mol−1 | 1.00 | infobox |
| Tecovirimat | Other names | ST-246 | 1.00 | infobox |
| Tecovirimat | PubChem CID | 16124688 | 1.00 | infobox |
| Tecovirimat | Routes of administration | By mouth, intravenous | 1.00 | infobox |
| Tecovirimat | Trade names | Tpoxx | 1.00 | infobox |
| Tecovirimat | UNII | F925RR824R | 1.00 | infobox |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.